Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,293 | 39,143 | 72,184 | 43,446 | 69,313 |
| Marketable Securities | 355,175 | 369,107 | 350,905 | 120,591 | 106,770 |
| Receivables | 243 | 172 | 197 | 496 | 1,828 |
| TOTAL | $390,699 | $410,839 | $426,555 | $167,606 | $181,499 |
| Non-Current Assets | |||||
| PPE Net | 3,484 | 3,551 | 3,342 | 3,496 | 3,747 |
| Intangibles | 27,190 | 27,190 | 27,190 | 30,690 | 30,690 |
| Other Non-Current Assets | 2,668 | 3,074 | 3,114 | 2,759 | 3,129 |
| TOTAL | $33,342 | $33,815 | $33,646 | $36,945 | $37,566 |
| Total Assets | $424,041 | $444,654 | $460,201 | $204,551 | $219,065 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,721 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,019 | 1,228 | 836 | 685 | 997 |
| Accrued Expenses | 9,234 | 12,000 | 10,253 | 7,851 | 7,023 |
| Other current liabilities | 2,505 | 1,554 | N/A | 4,621 | 7,585 |
| TOTAL | $14,560 | $16,528 | $14,176 | $14,488 | $16,977 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,296 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 11,380 | 7,354 | 9,313 | 7,781 | 7,922 |
| TOTAL | $11,380 | $8,650 | $9,313 | $7,781 | $7,922 |
| Total Liabilities | $25,940 | $25,178 | $23,489 | $22,269 | $24,899 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,754 | 46,735 | 46,664 | 46,482 | 39,615 |
| Common Shares | 47 | 47 | 47 | 40 | 40 |
| Retained earnings | -1,166,657 | -1,143,607 | -1,123,459 | -1,103,007 | -1,089,634 |
| Other shareholders' equity | 112 | 1,894 | 2,548 | 2,592 | 2,587 |
| TOTAL | $398,101 | $419,476 | $436,712 | $182,282 | $194,166 |
| Total Liabilities And Equity | $424,041 | $444,654 | $460,201 | $204,551 | $219,065 |